Lallous, N.; Snow, O.; Sanchez, C.; Parra Nuñez, A.K.; Sun, B.; Hussain, A.; Lee, J.; Morin, H.; Leblanc, E.; Gleave, M.E.;
et al. Evaluation of Darolutamide (ODM201) Efficiency on Androgen Receptor Mutants Reported to Date in Prostate Cancer Patients. Cancers 2021, 13, 2939.
https://doi.org/10.3390/cancers13122939
AMA Style
Lallous N, Snow O, Sanchez C, Parra Nuñez AK, Sun B, Hussain A, Lee J, Morin H, Leblanc E, Gleave ME,
et al. Evaluation of Darolutamide (ODM201) Efficiency on Androgen Receptor Mutants Reported to Date in Prostate Cancer Patients. Cancers. 2021; 13(12):2939.
https://doi.org/10.3390/cancers13122939
Chicago/Turabian Style
Lallous, Nada, Oliver Snow, Christophe Sanchez, Ana Karla Parra Nuñez, Bei Sun, Ahmed Hussain, Joseph Lee, Helene Morin, Eric Leblanc, Martin E. Gleave,
and et al. 2021. "Evaluation of Darolutamide (ODM201) Efficiency on Androgen Receptor Mutants Reported to Date in Prostate Cancer Patients" Cancers 13, no. 12: 2939.
https://doi.org/10.3390/cancers13122939
APA Style
Lallous, N., Snow, O., Sanchez, C., Parra Nuñez, A. K., Sun, B., Hussain, A., Lee, J., Morin, H., Leblanc, E., Gleave, M. E., & Cherkasov, A.
(2021). Evaluation of Darolutamide (ODM201) Efficiency on Androgen Receptor Mutants Reported to Date in Prostate Cancer Patients. Cancers, 13(12), 2939.
https://doi.org/10.3390/cancers13122939